August 28, 2009
Risk of Death After ACS Different for Men and Women
Women may have a slightly higher risk of death than men in the 30 days following an acute coronary syndrome (ACS) such as heart attack or unstable angina, according to a new study.
Cardiovascular disease is the leading cause of death in both men and women, accounting for one-third of all deaths. Although several studies have shown an improvement of prognosis in women over time, overall outcomes remain worse for women compared with men, providing a strong rationale for focusing on the study of sex-based differences in the outcome of ACS.
Of the 136,247 patients in this analysis, 28 percent were women. There were 102,004 patients (26 percent women) with ST-segment elevation myocardial infarction (STEMI, a certain pattern on an electrocardiogram following a heart attack); 14,466 with non-STEMI (29 percent women); and 19,777 with unstable angina (40 percent women). Women were older and had a higher prevalence of hypertension, hyperlipidemia, diabetes and heart failure. Men were more likely to be smokers and had a higher prevalence of prior heart attack and prior coronary artery bypass graft surgery.
"Perhaps the most striking findings in our analyses relate to the examination of mortality according to type of ACS. We found a significant interaction between sex and type of ACS, such that 30-day mortality risk among women was modestly higher than men only for those patients presenting with STEMI. In patients with NSTEMI and unstable angina, women had a lower adjusted 30-day mortality risk than men. In fact, the strongest finding after full adjustment was lower risk among women with unstable angina," the authors write.
The researchers also found that women who underwent catheterization were more likely than men to have non-obstructive coronary artery disease and less likely to have multi-vessel disease. The relationship between gender and 30-day mortality was similar across the levels of angiographic disease severity.
"Sex-based differences exist in 30-day mortality among patients with ACS and vary depending on clinical presentation. However, these differences are markedly attenuated following adjustment for clinical differences and angiographic data," the researchers concluded. "Understanding and considering these differences may lead to better risk stratification and treatment of all patients with ACS."
SOURCE: Journal of the American Medical Association (JAMA), August 26, 2009